ReviewInternational journal of heart failure2023
Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure.
Review in International journal of heart failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Depression and cardiovascular disease: mind the gap in the guidelines.European heart journal · 2025Pooled it
- Effectiveness of an Intervention to Improve Guideline-Directed Medications for Patients With Acute Heart Failure: A Randomized Clinical Trial.Journal of the American Heart Association · 2026Trial
- From Reflex to Reason: Does New-Onset Heart Failure Warrant a Routine Ischemic Evaluation?International journal of heart failure · 2026Article
- Observational
- An easy-to-use model for screening type 2 myocardial infarction in geriatric patients with acute coronary syndrome: a retrospective cohort study.Frontiers in medicine · 2026Article
- Development of Korean Standardized Heart Failure Registry: Experience From Integration of KorAHF and KorHF III.International journal of heart failure · 2026Review
- Addressing Cardiovascular Diseases Challenges in South Korea: Strategies to Improve Outcomes.Korean circulation journal · 2025Review
- Establishing a National Quality of Care Framework for Heart Failure in Korea: Keep Standards for Heart Failure (KSHF) Initiative.International journal of heart failure · 2025Review
- Exercise Hemodynamics and Sex-Specific Data in Asymptomatic Adults: An Exploratory Pilot Study.Diagnostics (Basel, Switzerland) · 2025Article
- Obesity and heart failure with preserved ejection fraction: focus on new drugs and future direction in medical treatment.The Korean journal of internal medicine · 2025Review
- Article
- Is early use of sodium-glucose cotransporter type 2 inhibitor (SGLT2i) necessary even in diabetic patients without cardiovascular disease: a prospective study regarding the effect of SGLT2i on left ventricular diastolic function.Journal of cardiovascular imaging · 2025Article
- Impact of discharge checklist on guideline-directed medical therapy and mid-term prognosis in heart failure.The Korean journal of internal medicine · 2024Observational
- Speckle tracking echocardiography: a reliable tool for right ventricle function evaluation in severe tricuspid regurgitation.Journal of cardiovascular imaging · 2024Article
- Temporal Trends in Clinical Characteristics and Outcomes for Peripartum Cardiomyopathy: The Nationwide Multicenter Registry Over 20 Years.Journal of the American Heart Association · 2024Article
- Blood pressure and heart failure: focused on treatment.Clinical hypertension · 2024Review
- Novel Insights Into the Pathogenesis of Obesity-Related High Output Heart Failure From Gene Expression Profiling.International journal of heart failure · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most patients with heart failure (HF) have multiple comorbidities, which impact their quality of life, aggravate HF, and increase mortality. Cardiovascular comorbidities include systemic and pulmonary hypertension, ischemic and valvular heart diseases, and atrial fibrillation. Non-cardiovascular comorbidities include diabetes mellitus (DM), chronic kidney and pulmonary diseases, iron deficiency and anemia, and sleep apnea. In patients with HF with hypertension and left ventricular hypertrophy, renin-angiotensin system inhibitors combined with calcium channel blockers and/or diuretics is an effective treatment regimen. Measurement of pulmonary vascular resistance via right heart catheterization is recommended for patients with HF considered suitable for implantation of mechanical circulatory support devices or as heart transplantation candidates. Coronary angiography remains the gold standard for the diagnosis and reperfusion in patients with HF and angina pectoris refractory to antianginal medications. In patients with HF and atrial fibrillation, long-term anticoagulants are recommended according to the CHA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.